The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients
- collapse Evaluation of the control level (GINA) of asthmatic patients consulting their general practitioner for a seasonal increase of respiratory symptoms (high and / or low), whether an inhaled corticotherapy is taken or not
- collapse CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.
- collapse KOSMOS - A project ensuring quality and cooperation in the COPD treatment
- collapse An Exploratory Study to Assess the Absolute Bioavailability of a Single Oral Dose of AZD9668 with Respect to an Intra-venous Microdose of [14C]AZD9668 in Healthy Male Subjects
- collapse An evaluation of efficacy and safety of corresponding doses of Pulmicort Turbuhaler and Pulmicort Respules in Japanese asthmatic adult patients (open, multicenter, phase III study)
- collapse A Retrospective Epidemiological Study to map out patients with Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD health care in Real-Life Primary Care during the first ten years of the 21th century.
- collapse A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60mg AZD9668 Administered Orally twice daily to subjects with Chronic Obstructive Pulmonary Disease (COPD) on treatment with Budesonide/Formoterol
- collapse A 12-week, randomised, double-blind, placebo-controlled, parallel group, multinational, phase IIb dose range finding study to evaluate the efficacy and safety of AZD9668 administered orally at 3 dose levels to patients with Chronic Obstructive Pulmonary Disease (COPD) on treatment with tiotropium
- collapse A phase I, randomised, double-blind, placebo-controlled, parallel-group, single-centre study to investigate the safety, tolerability and pharmacokinetics of multiple ascending doses of AZD3199 given once daily as inhaled formulation via Turbuhaler to healthy men.
